Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs
- 16 October 1995
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 58 (3) , 217-225
- https://doi.org/10.1016/0165-1781(95)02698-v
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regionsPeptides, 1993
- Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelinMetabolism, 1992
- Increased Angiotensin-(1–7) in Hypophysial-Portal Plasma of Conscious SheepNeuroendocrinology, 1992
- Chronic haloperidol and chlorpromazine treatment alters in vitro β-endorphin metabolism in rat brainEuropean Journal of Pharmacology, 1990
- Neuroleptic drug treatment alters in vitro central neurotensin metabolismPsychoneuroendocrinology, 1987
- Degradation of neurotensin by rabbit brain endo-oligopeptidase A and endo-oligopeptidase B (proline-endopeptidase)Biochemical and Biophysical Research Communications, 1983
- Distribution of post-proline cleaving enzyme in human brain and the peripheral tissuesMolecular and Cellular Biochemistry, 1980
- A Diagnostic InterviewArchives of General Psychiatry, 1978
- Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE)European Journal of Pharmacology, 1978
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960